U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938763) titled 'Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults' on March 06.
Brief Summary: A Phase I, Randomized, Double-blinded, Placebo-Controlled First-in-human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of J4 Dry Powder Capsule after Oral Administration of Single and Multiple Ascending Doses to Healthy Adults
Study Start Date: Feb. 14
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Intervention:
DRUG: J4
dry powder capsule
DRUG: Placebo
Placebo dry powder capsule
Recruitment Status: RECRUITING
Sponsor: QPS Holdings LLC
Published by HT Digital Content Services with...